BioScience continues to lead Baxter's sales
This article was originally published in Scrip
Executive Summary
Baxterhas continued its strong 2008 performance with a net income of $472 million in the third quarter, representing an increase of 19% compared with the same period last year. The company's total sales increased by 15% to $3.2 billion in the third quarter, $77 million above Morgan Stanley analysts' expectations, though this was significantly bolstered by a 6% favourable effect from exchange rates.